{"id":481575,"title":"Notice: Multiple Additions to the Prescription Drug List (PDL) [2022-08-17] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T17:00:39.426000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2022-08-17.html?wbdisable=true","snippet":"Notice: Multiple Additions to the Prescription Drug List (PDL) [2022-08-17] Date: August 17, 2022 Our file number: 22-109195-425 The purpose of this Notice of Amendment is to notify about the additions of avacopan, berotralstat, capmatinib, faricimab, mogamulizumab, selinexor,…","rawSnapshotUrl":"/api/snapshots/raw/481575","browseUrl":"https://replay.healtharchive.ca/job-6/20260106170039/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2022-08-17.html?wbdisable=true#ha_snapshot=481575","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}